Advertisement

The Latest

The following article is contributed by Matt Lau, corporate controller for Regent Surgical Health.

A new analysis of 18 studies about the use of bone morphogenic protein for lumbar fusions show the product doesn't significantly improve outcomes, according to a report in AAOS Now.

Advertisement